1. P423 Comparative efficacy of anti-tumour necrosis factor agents and vedolizumab in ulcerative colitis. (25th January 2019) Authors: Subramanian, S; Davis, R; MacParland, P; Dodd, S; Storey, D; Probert, C; Collins, P; Skouras, T; Steel, A; Derbyshire, E; Dibb, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P093 CD4 T-cell transcriptome analysis at baseline predicts clinical remission to anti-TNF agents in ulcerative colitis (UC). (25th January 2019) Authors: Subramanian, S; Rainbow, L; Gemmell, M; Hough, R; Haldenby, S; Gureviciute, A; Lofthouse, M; Martin, K; Probert, C Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P579 Randomised open-label controlled trial of ciprofloxacin/doxycycline/hydroxychloroquine combination compared with standard budesonide in active Crohn's disease (APRICOT). (15th January 2020) Authors: Rhodes, J M; Subramanian, S; Flanagan, P; Horgan, G; Martin, K; Mansfield, J; Parkes, M; Hart, A; Dallal, H; Iqbal, T; Butterworth, J; Culshaw, K; Probert, C Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S487 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PTH-049 Successful Reversal of High Titre Antibodies to Infliximab and Adalimumab with The Addition of Immunomodulator Therapy. (17th August 2016) Authors: Bond, A; Clark, K; Gregg, B; Collins, P; Dibb, M; Probert, C; Subramanian, S Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC-003 Efficacy and Safety of Golimumab Induction for Moderate to Severe Ulcerative Colitis in the United Kingdom: Results from the Go-Colitis Study. (17th August 2016) Authors: Probert, C; Gaya, D; Hamlin, PJ; Irving, P; Sebastian, S; Gillespie, G; Tate, H; Wheeler, C Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PTU-070 Patient-Reported Quality of Life During Golimumab Induction for Moderate to Severe Ulcerative Colitis in the United Kingdom: Results from The Go-Colitis Study. (17th August 2016) Authors: Irving, P; Probert, C; Gaya, D; Hamlin, PJ; Sebastian, S; Gillespie, G; Tate, H; Wheeler, C Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PTU-138 Feasibility Study of Volatile Organic Compounds in Constipation in Parkinson's Disease. (17th August 2016) Authors: Qureshi, S; Bond, A; Iwanejko, L; Probert, C Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PTH-009 New Generation High Definition Colonoscopes Increase Adenoma Detection within The Bowel Cancer Screening Programme. (17th August 2016) Authors: Bond, A; Fisher, G; Subramanian, S; O'Toole, P; Haslam, N; Probert, C; Cox, T; Sarkar, S Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 21 Patient-reported quality of life during golimumabinduction for moderate to severe ulcerative colitis in the united kingdom: results from the go-colitis study. (5th April 2017) Authors: Irving, P; Sebastian, S; Probert, C; Gaya, D; Hamlin, PJ; Gillespie, G; Tate, H; Wheeler, C Journal: Gut Issue: Volume 66(2017)Supplement 1 Page Start: A8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 20 Efficacy and safety of golimumab induction for moderate to severe ulcerative colitis in the united kingdom: results from the go-colitis. (5th April 2017) Authors: Probert, C; Gaya, D; Hamlin, PJ; Irving, P; Sebastian, S; Gillespie, G; Tate, H; Wheeler, C Journal: Gut Issue: Volume 66(2017)Supplement 1 Page Start: A8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗